We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$26B
AUM Growth
+$926M
Cap. Flow
-$759M
Cap. Flow %
-2.91%
Top 10 Hldgs %
34.84%
Holding
584
New
79
Increased
150
Reduced
231
Closed
76

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$179M
2
META icon
Meta Platforms (Facebook)
META
+$175M
3
DIS icon
Walt Disney
DIS
+$147M
4
NKE icon
Nike
NKE
+$146M
5
AAPL icon
Apple
AAPL
+$141M

Sector Composition

Rank Sector Weight
1 Technology 29.14%
2 Healthcare 22.1%
3 Consumer Discretionary 13.75%
4 Financials 10.22%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
376
DELISTED
Clovis Oncology, Inc.
CLVS
$527K ﹤0.01%
35,447
-54,964
-61% -$993K
ZGNX
377
DELISTED
Zogenix, Inc.
ZGNX
$526K ﹤0.01%
11,000
-59,164
-84% -$2.38M
MTCH icon
378
Match Group
MTCH
$8.84B
$522K ﹤0.01%
+7,753
New +$507K
AXSM icon
379
Axsome Therapeutics
AXSM
$12.4B
$515K ﹤0.01%
+20,000
New +$401K
MRTX
380
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$515K ﹤0.01%
5,000
-1,000
-17% -$77.9K
NVDA icon
381
NVIDIA
NVDA
$5.01T
$485K ﹤0.01%
118,120
MGTX icon
382
MeiraGTx Holdings
MGTX
$1.09B
$484K ﹤0.01%
18,000
+8,000
+80% +$165K
HZNP
383
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$481K ﹤0.01%
+20,000
New +$507K
CBIO
384
Crescent Biopharma
CBIO
$602M
$477K ﹤0.01%
+400
New +$478K
A icon
385
Agilent Technologies
A
$39.1B
$434K ﹤0.01%
5,811
MOH icon
386
Molina Healthcare
MOH
$10.3B
$429K ﹤0.01%
+3,000
New +$411K
DOW icon
387
Dow Inc
DOW
$21.6B
$425K ﹤0.01%
+8,621
New +$455K
MSCI icon
388
MSCI
MSCI
$40B
$421K ﹤0.01%
1,762
-788
-31% -$177K
GO icon
389
Grocery Outlet
GO
$891M
$415K ﹤0.01%
+12,617
New +$390K
HEES
390
DELISTED
H&E Equipment Services
HEES
$342K ﹤0.01%
11,769
-5,938
-34% -$165K
EA icon
391
Electronic Arts
EA
$52.4B
$339K ﹤0.01%
3,344
-85
-2% -$8.1K
CIB icon
392
Grupo Cibest SA
CIB
$20.4B
$335K ﹤0.01%
+6,555
New +$327K
INSM icon
393
Insmed
INSM
$23.2B
$333K ﹤0.01%
+13,000
New +$362K
ROK icon
394
Rockwell Automation
ROK
$51.4B
$312K ﹤0.01%
1,906
PVH icon
395
PVH
PVH
$3.71B
$308K ﹤0.01%
3,250
-81
-2% -$8.96K
MKC icon
396
McCormick & Company Non-Voting
MKC
$13.4B
$297K ﹤0.01%
3,838
-1,510
-28% -$116K
BR icon
397
Broadridge
BR
$17.2B
$294K ﹤0.01%
2,304
+2,119
+1,145% +$255K
ENTA icon
398
Enanta Pharmaceuticals
ENTA
$372M
$253K ﹤0.01%
+3,000
New +$270K
KR icon
399
Kroger
KR
$34.8B
$218K ﹤0.01%
10,050
-361
-3% -$8.78K
FATE icon
400
Fate Therapeutics
FATE
$281M
$203K ﹤0.01%
+10,000
New +$180K

Similar funds

Fred Alger Management's Q2 2019 Portfolio in Review

As of Q2 2019, Fred Alger Management held 584 positions worth $26B, up 3.7% from $25.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fred Alger Management's Q2 2019 filing shows 79 new, 150 increased, 231 reduced and 76 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 2,145,722 shares worth $65.1M. The largest sale was Alphabet (Google) Class C, an estimated $368M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q2 2019 buy was Pluralsight, Inc. Class A Common Stock: 2,145,722 shares worth $65.1M.
  • Fred Alger Management added most to Qualcomm in Q2 2019, an estimated $179M increase.
  • Fred Alger Management's biggest Q2 2019 reduction was Alphabet (Google) Class C, cutting an estimated $368M.
  • Fred Alger Management fully exited Cognizant in Q2 2019, selling an estimated $51M.
  • Fred Alger Management's ten largest holdings make up 35% of its $26B portfolio in Q2 2019.
  • Fred Alger Management opened 79 new positions and closed 76 in Q2 2019.
  • Fred Alger Management's portfolio value rose 3.7% quarter-over-quarter to $26B.

Based on Fred Alger Management's 13F filing for Q2 2019, filed 14 Aug 2019.